Biotechnology Stocks II: Compare Returns of S&P 500 to Y-mAbs Therapeutics, Inc. (YMAB)
S&P 500 prices are represented by SPDR® S&P 500® ETF (SPY) prices.
Prices for SPY and the designated stock are monthly closes adjusted for splits and dividends from Alpha Vantage.
Compare Returns for SPY and YMAB | ||
---|---|---|
Start Date | Oct-31-2018 | Oct-31-2018 |
Start Price | $173.92 | $24.56 |
End Date | Jun-11-2025 | Jun-11-2025 |
End Price | $601.36 | $4.93 |
Number Monthly Prices | 81 | 81 |
Min Date | Dec-31-2018 | Oct-31-2022 |
Min Price | $226.58 | $3.61 |
Max Date | Jun-11-2025 | Nov-30-2020 |
Max Price | $601.36 | $50.87 |
Total Return | 146.55% | -79.93% |
Annualized Return | 14.30% | -21.17% |
Current Value of $1,000 Purchase | $2,466 | $201 |
Number Returns | 3,240 | 3,240 |
Average Return | 39.04% | -25.16% |
Minimum Return | -23.93% | -92.90% |
Maximum Return | 165.40% | 362.60% |
Number Profitable Returns | 2,932 | 881 |
Percent Profitable Returns | 90.49% | 27.19% |
Number Unprofitable Returns | 308 | 2,359 |
Percent Unprofitable Returns | 9.51% | 72.81% |
Profitable to Unprofitable Returns Ratio | 9.52 | 0.37 |
YMAB Dollar-cost Average
YMAB Correlation with S&P 500
YMAB Trendline Chart
YMAB Moving Average Chart
YMAB Stock Return Map - See Patterns of Gains and Losses
YMAB Stock Returns/Purchase Dates